Abstract :
Objectives: Total blood homocysteine (Hcys) and folate levels have been investigated in association
with cognitive dysfunction in healthy but not in multimorbid elderly patients. We hypothesized that total serum
Hcys is an adequate marker to identify multimorbid elderly patients with cognitive dysfunction assessed by the
Short Cognitive Performance Test (SKT) and Mini-Mental State Examination (MMSE). Design: Cross-sectional
study. Setting: The study center was an acute geriatric hospital. Participants: A total of 189 multimorbid elderly
patients were recruited. Methods: Cognitive dysfunction was determined according to the SKT and MMSE.
Biochemical parameters (Hcys, folate, vitamin B12, hemoglobin), nutritional status (BMI, Mini Nutritional
Assessment, nutritional intake), and activities of daily living were assessed. Results: According to the SKT,
25.4% of patients showed no cerebral cognitive dysfunction, 21.2% had suspected incipient cognitive
dysfunction, 12.7% showed mild cognitive dysfunction, 9.0% had moderate cognitive dysfunction, and 31.7% of
patients were demented. The median plasma Hcys value was elevated by ~20% in multimorbid elderly patients,
independent of cognitive dysfunction. Serum folate and vitamin B12 concentrations were within normal ranges.
We did not find significant differences in nutritional status, activities of daily living, numbers of diseases or
medications, or selected biochemical parameters between the SKT groups. Conclusion: Elevated serum Hcys
levels with normal plasma folate and vitamin B12 concentrations were observed in multimorbid elderly patients.
The plasma Hcys level did not appear to be an important biological risk factor for cognitive dysfunction in
multimorbid geriatric patients
Keywords :
folate , homocysteine , multimorbid elderly. , Cognitive dysfunction